Onno Stolpe - Galapagos CEO
GLPGF Stock | USD 26.20 9.32 26.24% |
CEO
Mr. Onno van de Stolpe has served as Chief Executive Officer, Executive Director, Chairman of the Executive Committee of Galapagos NV since June 1999. He founded Galapagos in 1999 while he was Managing Director Genomics at Introgene . Prior to joining Introgene in 1998, he was Managing Director of Molecular Probes Europe. He established this European headquarters after joining Molecular Probes in the United States. Previously, he worked for the Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands. Mr. van de Stolpe started his career as Manager Business Development at MOGEN in Leiden. He has previously served as member of the supervisory board of the Stichting Institute for Human Organ and Disease Model Technologies and as a member of the board of directors of DCPrime B.V since 1999.
Age | 58 |
Tenure | 25 years |
Phone | 32 1 534 29 00 |
Web | https://www.glpg.com |
Galapagos Management Efficiency
The company has return on total asset (ROA) of (0.0119) % which means that it has lost $0.0119 on every $100 spent on assets. This is way below average. Galapagos' management efficiency ratios could be used to measure how well Galapagos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 2 records | CEO Age | ||
Brian Pedlar | Covalon Technologies | N/A | |
Gilles Gagnon | Ceapro Inc | 62 |
Management Performance
Return On Equity | 0.0021 | |||
Return On Asset | -0.0119 |
Galapagos NV Leadership Team
Elected by the shareholders, the Galapagos' board of directors comprises two types of representatives: Galapagos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galapagos. The board's role is to monitor Galapagos' management team and ensure that shareholders' interests are well served. Galapagos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galapagos' outside directors are responsible for providing unbiased perspectives on the board's policies.
Rajesh Parekh, Non-Executive Chairman of the Board | ||
Andre Hoekema, Sr. VP of Corporate Devel. | ||
Katrine Bosley, Independent Non-Executive Director | ||
John Montana, Managing Argenta | ||
Walid AbiSaab, Member of the Executive Committee, Chief Medical Officer | ||
Marieke Vermeersch, Head Communication | ||
Howard Rowe, Non-Executive Independent Director | ||
Bob Rajan, Non-Executive Independent Director | ||
Harrold Barlingen, Non-Executive Director | ||
Raj Parekh, Non-Executive Chairman of the Board | ||
Elizabeth Goodwin, VP Corporate Communications & Investor Relations | ||
Mary Kerr, Non-Executive Independent Director | ||
Michele MBA, Chief Board | ||
Piet Wigerinck, Chief Scientific Officer | ||
Chantal Tasset, Head Devel | ||
Sofie Gijsel, Head Relations | ||
MBA MBA, COO Pres | ||
Bart Filius, CFO | ||
Christine Mummery, Non-Executive Independent Director | ||
Werner Cautreels, Non-Executive Independent Director | ||
Onno Stolpe, Co-Founder, CEO, Managing Director and Executive Director |
Galapagos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Galapagos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0021 | |||
Return On Asset | -0.0119 | |||
Profit Margin | 0.01 % | |||
Operating Margin | (0.17) % | |||
Current Valuation | (2.11 B) | |||
Shares Outstanding | 65.84 M | |||
Shares Owned By Insiders | 26.24 % | |||
Shares Owned By Institutions | 32.13 % | |||
Price To Earning | 454.11 X | |||
Price To Book | 0.92 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galapagos NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Galapagos NV information on this page should be used as a complementary analysis to other Galapagos' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Galapagos Pink Sheet analysis
When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |